Tags: Drug.
Iratumumab is a human monoclonal antibody used in the treatment of oncological diseases such as relapsed refractory CD30-positive lymphoma including Hodgkin’s disease.This drug was developed by Medarex Inc.
Loading...
This page contains content from the copyrighted Wikipedia article "Iratumumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.